---
figid: PMC7105297__zbc9992020700001
figlink: pmc/articles/PMC7105297/figure/F1/
number: F1
caption: 'Genome-wide CRISPR/Cas9 screen for positive regulators of SL biosynthesis.
  A, schematic showing SL biosynthetic pathway leading to the production of Gb3. Genes
  required for the pathway are shown in green. B, cell viabilities of WT HeLa cells
  (control) and SPTLC1 KO HeLa cells with or without Shiga toxin (2 ng/ml) treatment
  for 72 h. Data are expressed as mean ± S.D. (error bars) (n = 3). C, representative
  immunoblot analysis of SPTLC1 protein expression in WT (control) and SPTLC1 KO HeLa
  cells. β-Actin was used as a loading control. D, flow cytometry analysis of WT (control)
  and SPTLC1 KO HeLa cells stained with anti-CD77 antibody. Left, representative dot
  plot of cell-surface expression of Gb3. Right, quantification of Gb3 expression
  (mean ± S.D.; n = 3). Unpaired t test was used: **, p ≤ 0.01; ***, p ≤ 0.001. E,
  schematic representation of the genome-wide CRISPR/Cas9 screening strategy undertaken
  to identify genes required for Shiga toxin resistance in HeLa cells. F, scatterplot
  showing the ranking of positively selected genes from MAGeCK analysis. The x axis
  indicates positive ranking of individual genes, and the y axis indicates −log10
  values of corresponding robust ranking aggregation (RRA) score. The 20 top-ranking
  genes are highlighted and labeled. Inset, scatterplot showing log -fold change for
  all of the genes. Genes involved in the SL biosynthetic pathway that show positive
  log -fold change in the toxin-resistant group are highlighted in green. AHR is highlighted
  in red.'
pmcid: PMC7105297
papertitle: A genome-wide CRISPR/Cas9 screen reveals that the aryl hydrocarbon receptor
  stimulates sphingolipid levels.
reftext: Saurav Majumder, et al. J Biol Chem. 2020 Mar 27;295(13):4341-4349.
pmc_ranked_result_index: '59328'
pathway_score: 0.5442314
filename: zbc9992020700001.jpg
figtitle: Genome-wide CRISPR/Cas9 screen for positive regulators of SL biosynthesis
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7105297__zbc9992020700001.html
  '@type': Dataset
  description: 'Genome-wide CRISPR/Cas9 screen for positive regulators of SL biosynthesis.
    A, schematic showing SL biosynthetic pathway leading to the production of Gb3.
    Genes required for the pathway are shown in green. B, cell viabilities of WT HeLa
    cells (control) and SPTLC1 KO HeLa cells with or without Shiga toxin (2 ng/ml)
    treatment for 72 h. Data are expressed as mean ± S.D. (error bars) (n = 3). C,
    representative immunoblot analysis of SPTLC1 protein expression in WT (control)
    and SPTLC1 KO HeLa cells. β-Actin was used as a loading control. D, flow cytometry
    analysis of WT (control) and SPTLC1 KO HeLa cells stained with anti-CD77 antibody.
    Left, representative dot plot of cell-surface expression of Gb3. Right, quantification
    of Gb3 expression (mean ± S.D.; n = 3). Unpaired t test was used: **, p ≤ 0.01;
    ***, p ≤ 0.001. E, schematic representation of the genome-wide CRISPR/Cas9 screening
    strategy undertaken to identify genes required for Shiga toxin resistance in HeLa
    cells. F, scatterplot showing the ranking of positively selected genes from MAGeCK
    analysis. The x axis indicates positive ranking of individual genes, and the y
    axis indicates −log10 values of corresponding robust ranking aggregation (RRA)
    score. The 20 top-ranking genes are highlighted and labeled. Inset, scatterplot
    showing log -fold change for all of the genes. Genes involved in the SL biosynthetic
    pathway that show positive log -fold change in the toxin-resistant group are highlighted
    in green. AHR is highlighted in red.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SPTLC2
  - SPTSSA
  - SPTLC1
  - A4GALT
  - KDSR
  - UGCG
  - GOLPH3
  - TM9SF2
  - ARPC3
  - ACTR2
  - AHR
  - CERS2
  - ACTR3
  - ARPC4
  - UGP2
  - VPS53
  - TMEM165
  - NCKAP1
  - TNFRSF11A
  - Serine
  - palmitoyl
  - 3-keto-dihydrosphingosine
  - Sphinganine
  - Lactosylceramide
  - Dihydroceramide
  - Ceramide
  - Glucosylceramide
genes:
- word: SPTLC2
  symbol: SPTLC2
  source: hgnc_symbol
  hgnc_symbol: SPTLC2
  entrez: '9517'
- word: SPTSSA
  symbol: SPTSSA
  source: hgnc_symbol
  hgnc_symbol: SPTSSA
  entrez: '171546'
- word: SPTLC1
  symbol: SPTLC1
  source: hgnc_symbol
  hgnc_symbol: SPTLC1
  entrez: '10558'
- word: A4GALT
  symbol: A4GALT
  source: hgnc_symbol
  hgnc_symbol: A4GALT
  entrez: '53947'
- word: SPTLC1
  symbol: SPTLC1
  source: hgnc_symbol
  hgnc_symbol: SPTLC1
  entrez: '10558'
- word: KDSR
  symbol: KDSR
  source: hgnc_symbol
  hgnc_symbol: KDSR
  entrez: '2531'
- word: SPTLC1
  symbol: SPTLC1
  source: hgnc_symbol
  hgnc_symbol: SPTLC1
  entrez: '10558'
- word: SPTLC1
  symbol: SPTLC1
  source: hgnc_symbol
  hgnc_symbol: SPTLC1
  entrez: '10558'
- word: UGCG
  symbol: UGCG
  source: hgnc_symbol
  hgnc_symbol: UGCG
  entrez: '7357'
- word: SPTLC1
  symbol: SPTLC1
  source: hgnc_symbol
  hgnc_symbol: SPTLC1
  entrez: '10558'
- word: SPTLC1
  symbol: SPTLC1
  source: hgnc_symbol
  hgnc_symbol: SPTLC1
  entrez: '10558'
- word: GOLPH3
  symbol: GOLPH3
  source: hgnc_symbol
  hgnc_symbol: GOLPH3
  entrez: '64083'
- word: TM9SF2
  symbol: TM9SF2
  source: hgnc_symbol
  hgnc_symbol: TM9SF2
  entrez: '9375'
- word: ARPC3
  symbol: ARPC3
  source: hgnc_symbol
  hgnc_symbol: ARPC3
  entrez: '10094'
- word: SPTSSA
  symbol: SPTSSA
  source: hgnc_symbol
  hgnc_symbol: SPTSSA
  entrez: '171546'
- word: UGCG
  symbol: UGCG
  source: hgnc_symbol
  hgnc_symbol: UGCG
  entrez: '7357'
- word: ACTR2
  symbol: ACTR2
  source: hgnc_symbol
  hgnc_symbol: ACTR2
  entrez: '10097'
- word: UGCG
  symbol: UGCG
  source: hgnc_symbol
  hgnc_symbol: UGCG
  entrez: '7357'
- word: '"SPTSSA'
  symbol: SPTSSA
  source: hgnc_symbol
  hgnc_symbol: SPTSSA
  entrez: '171546'
- word: SPTLC2
  symbol: SPTLC2
  source: hgnc_symbol
  hgnc_symbol: SPTLC2
  entrez: '9517'
- word: A4GALT
  symbol: A4GALT
  source: hgnc_symbol
  hgnc_symbol: A4GALT
  entrez: '53947'
- word: AHR
  symbol: AHR
  source: hgnc_symbol
  hgnc_symbol: AHR
  entrez: '196'
- word: •CERS2
  symbol: CERS2
  source: hgnc_symbol
  hgnc_symbol: CERS2
  entrez: '29956'
- word: SPTLC2
  symbol: SPTLC2
  source: hgnc_symbol
  hgnc_symbol: SPTLC2
  entrez: '9517'
- word: ACTR3
  symbol: ACTR3
  source: hgnc_symbol
  hgnc_symbol: ACTR3
  entrez: '10096'
- word: A4GALT
  symbol: A4GALT
  source: hgnc_symbol
  hgnc_symbol: A4GALT
  entrez: '53947'
- word: AHR
  symbol: AHR
  source: hgnc_symbol
  hgnc_symbol: AHR
  entrez: '196'
- word: SPTLC1
  symbol: SPTLC1
  source: hgnc_symbol
  hgnc_symbol: SPTLC1
  entrez: '10558'
- word: ARPC4
  symbol: ARPC4
  source: hgnc_symbol
  hgnc_symbol: ARPC4
  entrez: '10093'
- word: UGP2
  symbol: UGP2
  source: hgnc_symbol
  hgnc_symbol: UGP2
  entrez: '7360'
- word: SPTLC1
  symbol: SPTLC1
  source: hgnc_symbol
  hgnc_symbol: SPTLC1
  entrez: '10558'
- word: VPS53
  symbol: VPS53
  source: hgnc_symbol
  hgnc_symbol: VPS53
  entrez: '55275'
- word: TMEM165
  symbol: TMEM165
  source: hgnc_symbol
  hgnc_symbol: TMEM165
  entrez: '55858'
- word: NCKAP1
  symbol: NCKAP1
  source: hgnc_symbol
  hgnc_symbol: NCKAP1
  entrez: '10787'
- word: rank
  symbol: RANK
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF11A
  entrez: '8792'
chemicals:
- word: Serine
  source: MESH
  identifier: C047902
- word: palmitoyl
  source: MESH
  identifier: C032023
- word: 3-keto-dihydrosphingosine
  source: MESH
  identifier: C005682
- word: Sphinganine
  source: MESH
  identifier: C005682
- word: Lactosylceramide
  source: MESH
  identifier: D007790
- word: Dihydroceramide
  source: MESH
  identifier: C109343
- word: Ceramide
  source: MESH
  identifier: D002518
- word: Glucosylceramide
  source: MESH
  identifier: D005963
diseases: []
figid_alias: PMC7105297__F1
redirect_from: /figures/PMC7105297__F1
figtype: Figure
---
